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Spontaneous puberty in girls with 
early diagnosis of Turner syndrome
Puberdade espontânea em meninas com 
diagnóstico precoce de síndrome de Turner
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Maria Tereza Matias Baptista1,3, Sofia Helena Valente Lemos-Marini2,  
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ABSTRACT
Objective: To verify if the frequency of spontaneous pubertal development among girls with Tur-
ner syndrome (TS) diagnosed in infancy and childhood is greater than that of patients diagno-
sed later. Subjects and methods: Thirty three girls aged < 10 years at the time of diagnosis were 
evaluated regarding pubertal development. The frequency of spontaneous puberty was compa-
red with that of girls aged > 13 years diagnosed at the same service. Results: Sixteen of 32 in-
formative patients had signs of spontaneous puberty, a frequency greater than that of patients 
diagnosed later. In six patients, there was no progression of puberty; menarche occurred in six, 
and one became pregnant, but the fetus was a stillborn. Spontaneous puberty was absent in all 
cases with 45,X karyotype. Conclusions: The greater prevalence of spontaneous puberty in girls 
whose diagnosis was not based on pubertal delay suggests that, among those diagnosed later, 
there is a bias towards patients with hypogonadism. Arq Bras Endocrinol Metab. 2012;56(9):653-7
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RESUMO
Objetivo: Verificar se a frequência de puberdade espontânea em meninas com síndrome de Tur-
ner (ST) diagnosticadas na infância é superior a de pacientes diagnosticadas posteriormente. 
Sujeitos e métodos: Foram avaliadas 33 meninas < 10 anos ao diagnóstico quanto ao desen-
volvimento puberal. A frequência de puberdade espontânea foi comparada com a de pacientes 
com mais de 13 anos diagnosticadas no mesmo serviço. Resultados: Dezesseis das 32 pacientes 
informativas tiveram sinais puberais espontâneos, frequência superior a daquelas diagnostica-
das posteriormente. Em seis delas, não houve progressão da puberdade; a menarca ocorreu 
em seis casos e uma paciente ficou grávida, porém o feto foi natimorto. Em todos os casos com 
cariótipo 45,X não ocorreu puberdade espontânea. Conclusões: A maior prevalência de puber-
dade espontânea em meninas cujo diagnóstico não se baseou em atraso puberal sugere que 
naquelas detectadas posteriormente haja distorção em favor de pacientes com hipogonadismo. 
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INTRODUCTION
Turner syndrome (TS) is characterized by the pres-ence of an X chromosome and total or partial loss of 
the second sex chromosome. Cytogenetic findings include 
the 45,X karyotype, and a variety of mosaics and struc-
tural sex chromosome abnormalities. The phenotype is 
highly variable, with various dysmorphic signs, congenital 
defects of the heart, kidneys and collecting system, as well 
as autoimmune and endocrine disorders, among others. 
However, the most frequent findings in TS patients are 
short stature and primary hypogonadism (1). 
In 45,X fetuses, primordial germ cells migrate to the 
genital ridges, and ovaries develop normally until the 18th 
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week of gestation. Afterward, there is an accelerated pro-
cess of germ-cell loss, which leads to severe impairment 
of folliculogenesis and increase of connective tissue, ulti-
mately resulting in a contracted fibrous “streak” gonad 
(2). In TS patients, the diphasic pattern of follicle-stim-
ulating hormone (FSH) and luteinizing hormone (LH) 
is similar to that of normal individuals, but gonadotropin 
concentrations are higher in infancy and in late child-
hood/adolescence (3). When measured by conventional 
radioimmunoassay, FSH and LH levels around mid-
childhood are similar to those of normal children (3); 
however, gonadotropin levels may be above the normal 
range when measured by ultrasensitive immunofluoro-
metric or immunochemiluminometric assays (4,5). 
Hypergonadotropic hypogonadism was initially con-
sidered an invariable feature of TS. In fact, all patients 
described by Henry Turner (6) had sexual infantilism, 
and textbooks from the 1960s to the 1980s stated that 
hypogonadism and sterility were found in almost all 
cases. Thus, in early studies, diagnosis was more fre-
quently carried out in patients whose clinical features 
were considered typical by health care professionals in 
that given moment, such as primary hypogonadism.
In the 1990s, however, researchers recognized that 
about 21-34% of girls with TS had adequate circulating 
estrogen to enter pubertal development. In many of these 
cases, hormone production could also enable induction 
of complete secondary sex differentiation and menstrua-
tion; afterwards, there could be cessation of menstrual 
cycles (secondary amenorrhea), or periods could remain 
regular, allowing these girls to be fertile (7-9). 
In 1997, an evaluation of 430 teenage girls with TS 
revealed that 255 (41%) had some degree of sponta-
neous pubertal development, and 84 of them (19.5%) 
had complete pubertal development and menses (10). 
As a consequence, sex hormone replacement therapy 
(HRT) should only be initiated when there are no signs 
of spontaneous puberty at the age of 12-13 years, and 
patients show high serum gonadotropins levels (1,11).
There is a predominance of mosaics among this 
patient population with spontaneous puberty, but this 
may also be observed in patients with an apparently ho-
mogeneous 45,X karyotype (12). Spontaneous fertility 
may occur in 1.8% of cases, including those with a 45,X 
chromosome constitution (12).
Thus, the analysis of studies published in the past de-
cades revealed a progressive increase in the diagnosis of 
girls with spontaneous puberty, which is certainly due to 
increased awareness of clinicians to the high phenotypic 
variability of this syndrome, leading to early diagnosis of 
cases without a TS stereotype. However, the proportion 
of cases of TS with spontaneous pubertal development 
may be even greater, because most studies include patients 
diagnosed in adolescence or later, when hypogonadism 
becomes evident. The aim of this study was to verify if 
the frequency of spontaneous puberty among girls with 
TS who were diagnosed in infancy and childhood were 
greater than that observed among girls diagnosed later.
PATIENTS AND METHODS
Our initial sample comprised 157 girls with TS who 
were referred to our service for disorders of sex deve-
lopment between 1988 and 2006 (13). Among them, 
68 had been diagnosed at 13 years of age or more, and 
32 between 10 and 12.99 years of age. Fifty seven had 
been diagnosed in infancy or childhood, before 10 
years of age; 48 of them were followed up thereafter at 
the University Hospital. 
The reason for referral varied with age (Table 1). 
While all girls under 10 years were referred due to short 
stature and/or TS stigmata, two thirds of those aged 13 
years or more were seen because of pubertal delay and/
or primary amenorrhea or secondary amenorrhea, with 
or without mention of short stature. In the interme-
diate group (10-12.99 years), short stature and/or TS 
stigmata were the most frequent reasons, but pubertal 
delay and/or primary amenorrhea were also mentioned. 
There were no significant differences regarding karyo-
type within the three age groups (Table 2; p = 0.501).
Table 1. Reason of referral of the 157 girls with Turner syndrome seen at 
our service between 1988 and 2006, according to the age group
Reason for referral
Age at first appointment
< 10 
years
10-12.99 
years
≥ 13 
years Total
TS stigmata 18 1 1 20
Short stature 34 18 15 67
Short stature + TS 
stigmata 4 6 3 13
Pubertal delay and/or 
primary amenorrhea 0 0 12 12
Short stature + pubertal 
delay and/or primary 
amenorrhea 0 5 29 34
Secondary amenorrhea 0 0 4 4
Infertility 0 0 1 1
Not specified 1 2 3 6
Total 57 32 68 157
Spontaneous puberty in Turner syndrome
Co
py
rig
ht
©
 A
BE
&
M
 to
do
s o
s d
ire
ito
s r
es
er
va
do
s.
655Arq Bras Endocrinol Metab. 2012;56/9
Fourteen out of the 48 patients diagnosed in in-
fancy or childhood had not reached adolescence in the 
last appointment in our service (< 10 years), and could 
not be included in the study, as well as a girl who had 
initiated HRT before the age of ten in another service. 
Thus, the number of patients included in the study was 
33, all of them followed up by the same team of pedi-
atric endocrinologists. Their ages ranged from 0.1 to 
9.87 years at diagnosis, and 14 were diagnosed before 
5 years of age. At the time this study was conducted, 
age range was 10.6 to 28.3 years. Twelve (36.4%) had 
a 45,X karyotype, 11 (33.3%) were 45,X/46,XX, and 
10 (30.3%) had various structural aberrations of sex 
chromosomes (Table 3). At least 50 metaphases were 
analyzed from each patient.
The following data were obtained from the patients’ 
medical records: occurrence of signs of spontaneous 
puberty based on breast development and serum levels 
of FSH and LH (measured by electrochemilumines-
cence); and, among patients with spontaneous pubertal 
development, age at menarche, regularity of menses, 
and occurrence of gestation. Persistent elevated levels 
of FSH (> 25.8mIU/mL) and LH (> 7.7 mIU/mL), 
and absence of breast development were considered 
consistent with absence of spontaneous puberty.
Besides a descriptive analysis, the proportion of pa-
tients with spontaneous pubertal development in this 
sample was compared with that observed among pa-
tients diagnosed in our service at the same period with 
more than 13 years of age, when pubertal delay was 
fully characterized (13). The frequency of spontaneous 
pubertal development was also compared between girls 
with a 45,X constitution and other karyotypes, and be-
tween those diagnosed before and after 5 years of age. 
Finally, it was also verified if age at diagnosis (before 
and after 5 years of age) were similar between 45,X pa-
tients and those with other karyotypes. Comparisons 
were done by Fisher’s exact test, and the level of signifi-
cance was set at 0.05. The study was approved by the 
Institutional Review Board, and data from the medical 
records were collected in 2010.
RESULTS
Sixteen girls had spontaneous pubertal development, 
and 16 had absence of pubertal signs associated with 
high levels of gonadotropins. At the onset of HRT in 
the latter group, which occurred at a mean age of 12.3 
years (range: 10.5 to 14 years), mean levels of FSH 
and LH were 128.17 mIU/mL (range: 67.32 to 201 
mIU/mL) and 30.20 mIU/mL (range: 8.10 to 110 
mIU/mL), respectively. Another patient, who had a 
45,X/46,XX karyotype, had normal serum levels of 
FSH and LH (4.26 IU/L and 6.78 IU/L, respecti-
vely) in the last appointment at 10.6 years of age, but 
no signs of spontaneous puberty, and could not be in-
cluded in either of these groups. Thus, in 50% of the 
informative cases (16/32), there were signs of spon-
taneous puberty, a frequency significantly greater than 
that found in the group of patients with more than 13 
years of age diagnosed at our service in the same period 
(18/63 or 28.6%; p = 0.039) (13). 
In 6/16 girls with spontaneous pubertal develop-
ment, there was no progression of puberty. They pre-
sented only breast development (until Tanner breast 
stage 2 – B2 – in three cases, B3 in two, and B4 in one 
case), and subsequent clinical and hormonal evidence 
of ovarian failure led to the institution of HRT, which 
occurred at a mean age of 13.7 years (range: 12.4 to 
15.5 years). Menarche occurred in six of the remaining 
Table 2. Cytogenetic findings of the 157 girls with Turner syndrome seen 
at our service between 1988 and 2006, according to the age group
Karyotype
Age at first appointment
< 10 
years
10-12.99 
years ≥ 13 years Total
45,X 24 12 25 61
Mosaics without 
structural 
abnormalities
15 5 20 40
Structural 
abnormalities ± 
mosaicism
18 15 23 56
Total 57 32 68 157
Table 3. Occurrence of spontaneous pubertal development among 32 
patients with Turner syndrome diagnosed before the age of 10, according 
to chromosome constitution 
Karyotype
Spontaneous pubertal development
Present Absent Total
Complete Arrested
45,X 0 0 12 12
45,X/46,XX 9 1 0 10
Structural abnormalities 1 5 4 10
45,X/46,XX/47,XX,+mar 1 0 0 1
45,X/46,XX/46,X,i(Xq) 0 1 0 1
45,X/46,X,+mar 0 2 3 5
45,X/46,X,i(Xq) 0 1 0 1
46,X,i(Xq) 0 1 1 2
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ten patients, with a mean age of 13.7 years (range: 12.0 
to 15.8 years); the other four patients were aged 12.4 
to 14.0 years in the last appointment. 
Among those who had menses, whose ages in 
the last appointment ranged from 14.4 to 23.1 years 
(mean: 18.2 years), there were no cases of secondary 
amenorrhea or irregular menstrual cycles. One of the 
girls became pregnant at 24 years of age. Intrauterine 
growth restriction was detected in the second trimester 
of pregnancy and, at 26 weeks of gestation, the fetus 
died in utero. The fetal karyotype was 46,XY, and no 
post-mortem examination was carried out.
Within the group of 32 informative patients, none 
of the 12 girls with a 45,X karyotype had spontane-
ous pubertal development. On the other hand, sponta-
neous pubertal signs were found in 16 of the 20 patients 
with other chromosome constitutions (p < 0.001), 
including all ten girls with a 45,X/46,XX karyotype. 
The percentage of the 45,X cell line in the cases with a 
45,X/46,XX karyotype ranged from 4% (two cases) to 
70% (one case) (mean: 20%). Among ten patients with 
structural aberrations, six had spontaneous pubertal de-
velopment, including two patients with a mosaic 46,XX 
cell line. Within the six patients with arrested puberty, 
five had structural sex chromosome aberrations, and 
only one had a 45,X/46,XX karyotype (Table 3). 
Though not significant, the frequency of sponta-
neous pubertal development was lower among girls 
diagnosed before 5 years of age (4/14) than among 
those diagnosed between 5 and 10 years (12/18; p = 
0.073). In addition, patients diagnosed before 5 years 
of age had more frequently a 45,X karyotype (8/14) 
than those diagnosed between 5 and 10 years (4/18; 
p = 0.068).
DISCUSSION
Although infertility is an important challenge affecting 
girls and women with TS, sexual development is also 
a sensitive issue, particularly during adolescence (14). 
The finding of a significantly greater frequency of spon-
taneous pubertal development in girls diagnosed before 
the age of 10 who were not diagnosed based on puber-
tal delay suggests that, among those with late diagnosis 
(more than 13 years old), the search for medical atten-
tion due to absence of breast development and primary 
amenorrhea leads to a bias in the estimate of the pro-
portion of cases with spontaneous pubertal signs. Thus, 
although the relatively small number of patients in this 
sample may limit the power of the study, the frequency 
of spontaneous pubertal development in TS may be 
even greater than currently estimated. 
However, spontaneous pubertal development may 
be arrested in any of its stages, including lack of pro-
gression of breast development associated with high 
levels of gonadotropins, as occurred with six of the 16 
patients, or secondary amenorrhea, which did not oc-
cur in this sample, maybe because there were no pa-
tients aged more than 23.1 years at the time this study 
was conducted. In this sample, some girls did not reach 
Tanner stage 3 of breast development, while others 
reached stage 5 and had regular menses, and one of 
them became pregnant, demonstrating the variability 
of the residual ovarian function.
Our results also show that the presence of a 
46,XX cell line confers a high probability of sponta-
neous pubertal development, as previously reported 
(10,15,16), indicating that the karyotype of infants 
and children with TS is relevant regarding future prog-
nosis of gonadal function and fertility. On the other 
hand, all girls with a 45,X karyotype had totally in-
duced puberty, different from other studies, in which 
spontaneous pubertal development was found in up 
to 14% of these cases (10,15). This may be due to 
the greater number of cells analyzed in this study (at 
least 50), which distinguishes the present study from 
other ones on this matter, and enables the diagnosis 
of low frequency mosaicism (17). 
The fact that patients with the 45,X karyotype are 
diagnosed earlier than those with other karyotypes has 
already been observed (18). In addition, significantly 
greater values of FSH have been observed in young 45,X 
patients when compared with those with 45,X/46,XX 
mosaicism (16). Thus, in spite of the greater frequency 
of spontaneous pubertal development among girls di-
agnosed in our service between 5 and 10 years of age, 
and the greater frequency of non-45,X patients in this 
age group not reaching significance, one may speculate 
that girls diagnosed in mid-childhood, usually during 
investigation of short stature, have the highest prob-
ability of having spontaneous pubertal development. 
In these cases, the levels of anti-Müllerian hormone 
(AMH) seem to be a promising marker of the remain-
ing ovarian function (19).
In conclusion, although it has generally been as-
sumed that absence of spontaneous puberty is an al-
most inevitable feature of TS, practitioners must be 
aware that there is, in fact, a high frequency of spon-
Spontaneous puberty in Turner syndrome
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taneous pubertal development in TS patients in order 
to prevent them from overlooking this condition in 
girls with short stature and/or other features of TS, but 
without hypogonadism. Additionally, the possibility of 
spontaneous puberty and fertility may not be ruled out 
when the diagnosis is carried out in infancy or child-
hood, particularly in the presence of a 46,XX cell line.
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